Evidence map›Paper›PMID 28155866›Full record

ArticleScientific reports2017

Reduced Activity of SRY and its Target Enhancer Sox9-TESCO in a Mouse Species with X*Y Sex Reversal.

Liang Zhao, Alexander Quinn, Ee Ting Ng, Frederic Veyrunes, Peter Koopman

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. CRISPR/Cas9-mediated knock-in of the murine Y chromosomal Sry gene.The Journal of reproduction and development · 2018
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Liang ZhaoInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Alexander QuinnInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Ee Ting NgInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Frederic VeyrunesInstitut des Sciences de l'Evolution de Montpellier, Université Montpellier II, CNRS, Montpellier, France.
Peter KoopmanInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
University of Queensland · AUInstitut des Sciences de l'Evolution de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In most eutherian mammals, sex determination is governed by the Y-linked gene Sry, but in African pygmy mice Mus minutoides, Sry action is overridden by a variant X chromosome (X*), yielding X*Y females. We hypothesized that X*Y sex reversal may be underpinned not only by neomorphic X chromosome functionality, but also by a compromised Sry pathway. Here, we show that neither M. minutoides SRY nor its target, the Sox9-TESCO enhancer, had appreciable transcriptional activity in in vitro assays, correlating with sequence degradation compared to Mus musculus counterparts. However, M. minutoides SRY activated its cognate TESCO to a moderate degree, and can clearly engage the male pathway in M. minutoides in the wild, indicating that SRY and TESCO may have co-evolved in M. minutoides to retain function above a threshold level. We suggest that weakening of the SRY/TESCO nexus may have facilitated the rise and spread of a variant X* chromosome carrying female-inducing modifier gene(s).

Indexed as

Amino Acid SequenceAnimalsBase SequenceEnhancer Elements, GeneticEvolution, MolecularFemaleGenes, ReporterHaplotypesHEK293 CellsHumansMaleMiceModels, GeneticPeptidesProtein StabilitySex Determination ProcessesPeptidespolyglutamineSex-Determining Region Y ProteinSOX9 Transcription Factor

Identifiers

PMID28155866
PMCPMC5290746
OpenAlexW2585627508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.